Dr. Andrew Gallimore
Dr. Gallimore is a neurobiologist, chemist, and pharmacologist interested in the relationship between psychedelic drugs, the brain, consciousness and the structure of reality. He is currently based at the Okinawa Institute of Science and Technology.
Dr. Gallimore’s research was published in the following journals:
“Evidence for the Role of the monB Genes in Polyether Ring Formation during Monensin Biosynthesis.” – Chemistry & Biology (2006)
“Restructuring consciousness –the psychedelic state in light of integrated information theory.” – Frontiers in Human Neuroscience (2015)
“Building Human Worlds – DMT and the Simulated Universe.” – PsyPress UK Journal (2015)
“DMT Research from 1956 to the Edge of Time.” – Neurotransmissions: Psychedelic Essays from Breaking Convention (2015)
“A Computational Model for the AMPA Receptor Phosphorylation Master Switch Regulating Cerebellar Long-Term Depression.” – PLOS Computational Biology (2016)
“A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience.” – Frontiers in Pharmacology (2016)
“Switching On Depression and Potentiation in the Cerebellum.” – Cell Reports (2018)